Kezar Life Sciences, Inc. (KZR)
Chart Events
Performance Outlook
| Previous Close | 3.2300 |
| Open | 3.2700 |
| Bid | 3.3000 x 900 |
| Ask | 3.3100 x 1300 |
| Day's Range | 3.2600 - 3.3650 |
| 52 Week Range | 3.1800 - 17.8000 |
| Volume | |
| Avg. Volume | 825,671 |
| Market Cap | 231.174M |
| Beta (5Y Monthly) | 0.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9700 |
| Earnings Date | May 10, 2023 - May 15, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.50 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for KZR
Related Research
- Kezar Life Sciences, Inc.Daily – Vickers Top Buyers & Sellers for 01/26/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat2 months agoArgus Research
- Business Wire
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., March 14, 2023--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune mediated and oncologic disorders, today reported financial results for the fourth quarter and year ended December 31, 2022 and provided a business update.
- Business Wire
Kezar Life Sciences to Change Virtual R&D Day Date to March 15, 2023
SOUTH SAN FRANCISCO, Calif., March 13, 2023--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Company will pull forward its virtual Research and Development (R&D) Day to Wednesday, March 15, 2023 at 4:30 pm ET/1:30 pm PT.
- Business Wire
Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023
SOUTH SAN FRANCISCO, Calif., March 06, 2023--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that it will host a virtual Research and Development (R&D) Day on Wednesday, March 22, 2023 at 4:30 pm ET/1:30 pm PT.
